What is the best treatment for end-stage renal disease?

American Journal of Medicine

Volumn 112, Issue 9, 2002, Pages 735-736

  Sehgal, Ashwini R ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; EDITORIAL; HEMODIALYSIS; HUMAN; INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 0037096725     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01110-5     Document Type: Editorial

References (12)

1. Barriers to adequate protein nutrition among hemodialysis patients
2. Monitoring dialysis patients' health status
3. Peritoneal and hemodialysis: Differences in patient characteristics at initiation
4. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis
5. Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting
6. Comparative mortality of hemodialysis and peritoneal dialysis in Canada
7. Peritoneal and hemodialysis: Mortality risk associated with initial patient characteristics
8. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis
9. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis
10. Daily and nocturnal hemodialysis: How do they stack up?